Navigation Links
Sensory in Biological Technology

Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board

... an excitatory ion channel, called TRPV1, on sensory nerve endings, and that TRPV1 functions as a ... of physical and chemical signals that regulate sensory neuron excitability under both normal and ... showed that a menthol receptor from primary sensory neurons is activated by cold thermal stimuli, and ...

Oprah, Luke Skywalker and Maradona -- new study investigates how our brains respond to them

... of the same individual using different sensory prompts. For example a neuron responded to three ... a very abstract way, even if evoked by different sensory modalities" The study breaks new ground by ... at the very end of these pathways for processing sensory information. "This work gives us further ...

Frost & Sullivan Recognizes Martek Biosciences for Unique and Customer-Focused Strategies With Customer Value Enhancement Award

... Canada. " life'sDHA has exceptional sensory characteristics; it does not adversely affect a product's sensory properties such as taste or odor," says Arthi. ... small-scale food production capabilities, sensory analysis and chemical analytical support. ...

Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601

... has proven effective in protecting motor and sensory nerve function from disease- induced nerve ... with mild to moderate diabetic peripheral sensory motor neuropathy in the legs. 110 subjects were ... conduct an electrical signal, and quantitative sensory testing (QST) with the Vibratron II instrument, ...

Vineland Welcomes Dr. Isabelle Lesschaeve as Research Chair, Sensory and Consumer Sciences

... Lesschaeve to the new role of Research Chair, sensory and Consumer Sciences. "As the Research Chair, sensory and Consumer Sciences at Vineland, Dr. Lesschaeve ... (France). She has 20 years of experience in sensory and consumer sciences with a focus on food and ...

FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer

... than or equal to 20%) included: peripheral sensory neuropathy 62% (Grade 3/4: 14%), fatigue/asthenia ... with capecitabine included: peripheral sensory neuropathy 65% (Grade 3/4: 21%), palmar-plantar ... by patients receiving IXEMPRA were peripheral sensory neuropathy, fatigue/asthenia, myalgia/arthralgia, ...

New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation

... with two types of primarily peripheral sensory neuropathy: an acute, reversible type of early ... cancer receiving adjuvant therapy were peripheral sensory neuropathy, neutropenia, thrombocytopenia, ... advanced colorectal cancer were peripheral sensory neuropathy, fatigue, neutropenia, nausea, ...

NeurogesX Receives European Commission Approval for Qutenza(TM)

... viruses, in cases of postherpetic neuralgia (PHN) and painful HIV-distal sensory polyneuropathy (HIV-DSP), or diseases, such as diabetes. An estimated ... pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' ...

Brain research shows past experience is invaluable for complex decision making

... the brain has to interpret and assign meaning to inherently uncertain sensory information - being able to do this is vital for our survival! This ... actually trained to learn the rules that determine the way we interpret sensory information.'' Dr Kourtzi and colleagues wanted to find out about the ...

Otonomy Introduces Scientific Advisory Board

... basis of hearing and balance as well as developing therapies to reverse sensory hair cell loss in the cochlea. He joined the faculty of Harvard Medical School after completing his postdoctoral work in sensory neuroscience at The Rockefeller University . Dr. Heller earned a Ph.D. ...

NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union

... viruses, in cases of postherpetic neuralgia (PHN) and painful HIV-distal sensory polyneuropathy (HIV-DSP), or diseases, such as diabetes. An ... pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' ...

Victhom announces the completion of the second phase of the apnea therapy development

... Company filed a patent application on detection of obstructive apnea from sensory signals in vagal nerve. The continued research has revealed that in fact, sensory signals in various nerves innervating the larynx and the breathing airway ...

Sangamo BioSciences Reports Third Quarter 2008 Financial Results

... were defined as greater than a 14% improvement in quantitative sensory testing (QST), greater than 0.8 meters/second (m/sec) improvement in ... with at least one "blocked nerve". The data demonstrate recovery of sensory nerve conduction velocity (NCV) in 75% of SB-509 treated subjects ...

NeurogesX Reports Second Quarter 2008 Results

... clinical studies of NGX-4010 in other indications (e.g., HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN), where it ... pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' ...

Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system

... trial have demonstrated that the Neurostep(TM) is capable of collecting sensory signals from a nerve and of stimulating the appropriate muscle groups, ... initial results suggest that the Neurostep(TM) is capable of collecting sensory signals from a nerve located in the thigh. The interim results also ...

NeurogesX Reports Second Quarter 2009 Results

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), ...

NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), ...

NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate ...

Sanofi-aventis Announces Second Quarter 2009 Results

... NV1FGF in critical ischemia of the lower legs, is complete. The Phase III study evaluating xaliproden in the prevention of severe peripheral sensory neuropathy induced by oxaliplatin in patients with metastatic colorectal cancer did not attain its primary end point. It was therefore decided to ...

Anesiva Receives NASDAQ Delisting Staff Determination Letter

... (p=0.005). The Phase 3 TKA trial, known as ACTIVE-2, also showed that Adlea's safety profile of adverse events, wound healing, and wound sensory function were similar to placebo over the study duration. Forward-Looking Statements Except for historical information, this ...

NeurogesX Added to Russell 3000 Index

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a ...

UCF team's advanced nerve cell system could help cure diabetic neuropathy, related diseases

... they can zero in on the causes of and solutions for demyelination. Researchers have achieved Myelination and nodes of Ranvier formation with sensory neurons, but accomplishing the same task with the motor nerves that play more critical roles in some diseases has remained an elusive goal. ...

Fruit fly steps in to fight human disease

... peripheral nervous system that affects 1 in 2,500 people worldwide. Patients suffer from progressive motor impairment, muscle wasting and weakness, sensory loss, and foot deformities. Affecting children and adults, the disease often starts with minor symptoms, gradually worsening over time. Presently CMT ...

NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a ...

New MIT radio chip mimics human ear

... says that engineers can learn a great deal from studying biological systems that have evolved over hundreds of millions of years to perform sensory and motor tasks very efficiently in noisy environments while using very little power. "Humans have a long way to go before their architectures ...

NeurogesX to Present at Needham Life Sciences Conference

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), ...

Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients

... during Prograf therapy (see PRECAUTIONS). Neurotoxicity, including tremor, headache, and other changes in motor function, mental status, and sensory function, was reported in approximately 55% of liver transplant recipients in the two randomized studies. Tremor occurred more often in ...

NeurogesX Reports First Quarter 2009 Results

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late-stage product portfolio is led by its product candidate QutenzaTM, a ...

NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a ...

Video: Turning Hope Into Reality - VA Research to Restore Veterans' Abilities

... optimized to the point where it can be manufactured and made available to our Veterans." Frederick Downs Jr., director of VA's Prosthetic and sensory Aids Service who lost his left arm during combat in Vietnam, says he was "brought to tears" recently when the DEKA arm allowed him to smoothly bring ...

NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting

... send aberrant pain signals to the brain, in the absence of harmful stimuli. It can result from viruses, in cases of PHN and painful HIV-distal sensory polyneuropathy (HIV-DSP), or diseases, such as diabetes. An estimated 8% of the world's population suffers from neuropathic pain. Treatments to ...

NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a ...

Vineland Enables Industries' Efforts to Build Agri-Science Research Cluster

... market opportunities for the Canadian horticulture industry," Brandle adds. Vineland's Research Chairs oversee three broad scientific disciplines: sensory and Consumer Sciences; Molecular Breeding and Genetics, and Horticulture Production Systems. Each Research Chair will work collaboratively with ...

NeurogesX to Present at 11th Annual BIO CEO & Investor Conference

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late-stage product portfolio is led by its product candidate QutenzaTM, a ...

Martek, General Mills Collaborate on Microencapsulation Technology for Food Applications

... to produce high-quality, cost-effective DHA powders for certain food applications, particularly long-shelf life products and applications with sensory and formulation challenges. Under the terms of the agreement, Martek is granted a perpetual and generally exclusive license, with respect to third ...

NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a ...

NeurogesX Reports Third Quarter 2008 Results

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a ...

NeurogesX to Report Third Quarter 2008 Financial Results

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a ...

NeurogesX Submits NDA for NGX-4010 Dermal Capsaicin Patch for Treatment of Postherpetic Neuralgia (PHN)

... pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a ...

Plexon Inc Delivers 500th "Harvey Box" : 25 Years of Neural Data Acquisition and Analysis Leads to 500th System Sale

... on the scientific community's understanding of the brain. Research areas include: neuroprosthetics and brain-machine interface research basic sensory perception and motor control attention, cognition, and decision-making learning, memory, and emotional processing sleep studies Some notable Plexon ...
Other Contents
(Date:4/23/2014)... technique used to read quickly. It involves visual ... words and/ or sentences. Similarly to humans, biological ... "read" genetic information. Genes that need to be ... the encoding message, the easier it will be ... Gulbenkian de Cincia (IGC, Portugal) and Centre for ...
(Date:4/22/2014)... -- There are all sorts of signaling strategies in ... colorful tails; satin bowbirds build specialized stick structures, called ... and European bitterling males show off bright nuptial coloration ... method to communicate with others. , ... have profound fitness implications for individuals that are either ...
(Date:4/22/2014)... 22, 2014) Biotechnology scientists must be aware of ... and licensing guidelines, according to a new paper from ... in the current issue of the journal Regenerative ... 2013 U.S. Supreme Court ruling in the case Association ... occurring genes are unpatentable. The court case and rulings ...
Breaking Biology News(10 mins):Cell division speed influences gene architecture 2Best practices in communication for the animal world 2Best practices in communication for the animal world 3New patenting guidelines are needed for biotechnology 2New patenting guidelines are needed for biotechnology 3
(Date:4/23/2014)... compound that targets an important brain receptor has a ... including relapse behavior, a University at Buffalo animal study ... this may be a novel lead compound for treating ... UB research was published as an online preview article ... study, the compound, RO5263397, severely blunted a broad range ...
(Date:4/23/2014)... methods that can rapidly screen a large cell ... inside that population has been seriously lacking," said ... the Royal Society of Chemistry journal Chemical ... his coworkers have developed a novel technique that ... Chem. Sci. , 2014, DOI: 10.1039/C4SC00578C, http://pubs.rsc.org/en/content/articlelanding/2014/sc/c4sc00578c#!divAbstract ...
(Date:4/23/2014)... as the United States, it may come as a surprise ... adequate food due to lack of money or other financial ... the University of Illinois using data from the National Health ... are dealing with hunger are also facing negative health and ... over age 60 faced the threat of hungerthat translates to ...
(Date:4/23/2014)... of Midlife Occupational and Leisure Time Physical Activity on ... activity in midlife increases the risk of mobility limitation ... risk. This is found in a study which followed ... study was conducted at the Gerontology Research Center in ... Heavy physical labor is often repetitive, wears the body ...
(Date:4/23/2014)... has been a rapidly evolving pursuit with many ... in the research road, scientists have found a ... with the disease. The report, which appears in ... have important implications for developing novel treatments. , ... that for years, research has suggested a link ...
Breaking Medicine News(10 mins):Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2
Other TagsOther Tags